Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report
Mediators of Inflammation · 2026-01 · 2026 (1)
DOI: 10.1155/mi/1686665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 15.07.2026. Verfasst von Dagmara Borkowska-Tatar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, National Reference Laboratory for Mycobacteria, Institute of Tuberculosis and Lung Diseases, Płocka Street 26, Warsaw, 01…. Hauptthemen laut MEDLINE: Latent Tuberculosis, Biomarkers, Tuberculosis. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Tuberculosis and Lung Diseases.
Abstract (Originalsprache)
Background
Latent tuberculosis infection (LTBI) is an important public health problem and a major source of future active tuberculosis (ATB) cases. In this preliminary study, we sought to identify host biomarkers that could potential differentiate between LTBI and ATB.
Methods
A total of 145 plasma samples obtained from antigen tubes of the QuantiFERON‐TB Gold Plus assay were analysed. Concentrations of 20 selected cytokines were determined using a multiplex bead‐based immunoassay (Luminex xMAP Technology). Cytokine profiles were compared between patients with ATB, LTBI, and non‐tuberculosis (TB)/LTBI controls. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis and multivariable logistic regression modelling.
Results
Comparison of cytokine profiles showed significant differences in 13 of 20 analysed markers between LTBI and ATB. Among all evaluated biomarkers, interleukin‐7 (IL‐7) demonstrated the highest diagnostic potential in differentiating the two conditions (95.9%), outperforming interferon‐gamma (IFN‐γ), the key component of current IFN‐γ release assay (IGRA) assays. A logistic regression model based on IL‐7 and IFN‐γ achieved high diagnostic accuracy (98.1%) in this study cohort.
Conclusion
These preliminary findings suggest that IL‐7, in combination with IFN‐γ, may serve as a promising candidate biomarker signature for distinguishing LTBI from ATB. Nevertheless, these findings are based on a single‐centre dataset and represent internal, non‐externally validated results. Therefore, external validation in independent multicentre cohorts is essential before any clinical application can be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, National Reference Laboratory for Mycobacteria, Institute of Tuberculosis and Lung Diseases, Płocka Street 26, Warsaw, 01-138, Poland.
- Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, Nowoursynowska Street 159c, Warsaw, 02-776, Poland, sggw.pl.
ORCID-Profile: Dagmara Borkowska-Tatar, Anna Zabost, Michał Czopowicz, Ewa Augustynowicz-Kopeć
Förderung
- Institute of Tuberculosis and Lung Diseases
Zitieren
APA
Borkowska-Tatar, D., Zabost, A., Czopowicz, M., & Augustynowicz-Kopeć, E. (2026). Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/1686665
Vancouver
Borkowska-Tatar D, Zabost A, Czopowicz M, Augustynowicz-Kopeć E. Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/1686665
BibTeX
@article{BorkowskaTatar2026,
author = {Borkowska-Tatar, Dagmara and Zabost, Anna and Czopowicz, Michał and Augustynowicz-Kopeć, Ewa},
title = {Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report},
journal = {Mediators of Inflammation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/mi/1686665}
}
EUVIMED